Frédéric Revah

3.6k total citations
42 papers, 3.0k citations indexed

About

Frédéric Revah is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Genetics. According to data from OpenAlex, Frédéric Revah has authored 42 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 16 papers in Cellular and Molecular Neuroscience and 15 papers in Genetics. Recurrent topics in Frédéric Revah's work include Virus-based gene therapy research (15 papers), Nicotinic Acetylcholine Receptors Study (10 papers) and Receptor Mechanisms and Signaling (9 papers). Frédéric Revah is often cited by papers focused on Virus-based gene therapy research (15 papers), Nicotinic Acetylcholine Receptors Study (10 papers) and Receptor Mechanisms and Signaling (9 papers). Frédéric Revah collaborates with scholars based in France, United States and Switzerland. Frédéric Revah's co-authors include Jean‐Luc Galzi, Jean Pierre Changeux, Jacques Mallet, Anne Devillers‐Thiéry, Daniel Bertrand, Jean‐Pierre Changeux, J.-P. Changeux, S. Bertrand, Nicolas Hussy and Christophe Mulle and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Frédéric Revah

42 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frédéric Revah France 26 2.2k 1.3k 390 341 332 42 3.0k
James W. Patrick United States 27 3.4k 1.5× 1.5k 1.2× 181 0.5× 557 1.6× 277 0.8× 34 4.1k
Erik S. Schweitzer United States 19 2.0k 0.9× 1.9k 1.5× 115 0.3× 135 0.4× 563 1.7× 24 3.1k
William N. Green United States 36 3.5k 1.6× 1.5k 1.1× 180 0.5× 234 0.7× 126 0.4× 59 4.4k
Lucy Rhee United States 13 3.6k 1.6× 1.8k 1.4× 286 0.7× 133 0.4× 67 0.2× 13 4.8k
Kumi Kaneko Japan 23 918 0.4× 379 0.3× 199 0.5× 247 0.7× 629 1.9× 49 2.0k
Emer S. Ferro Brazil 34 1.9k 0.9× 984 0.8× 185 0.5× 470 1.4× 67 0.2× 107 3.1k
Bruce D. Howard United States 29 1.4k 0.7× 959 0.7× 520 1.3× 157 0.5× 316 1.0× 64 2.3k
Aaron Voigt Germany 24 1.0k 0.5× 526 0.4× 119 0.3× 167 0.5× 742 2.2× 44 1.9k
Louis J. DeGennaro United States 22 1.5k 0.7× 814 0.6× 238 0.6× 254 0.7× 549 1.7× 30 2.9k
Irith Ginzburg Israel 32 1.9k 0.9× 778 0.6× 173 0.4× 189 0.6× 124 0.4× 64 2.8k

Countries citing papers authored by Frédéric Revah

Since Specialization
Citations

This map shows the geographic impact of Frédéric Revah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Revah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Revah more than expected).

Fields of papers citing papers by Frédéric Revah

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frédéric Revah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Revah. The network helps show where Frédéric Revah may publish in the future.

Co-authorship network of co-authors of Frédéric Revah

This figure shows the co-authorship network connecting the top 25 collaborators of Frédéric Revah. A scholar is included among the top collaborators of Frédéric Revah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frédéric Revah. Frédéric Revah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Balavoine, Fabrice, et al.. (2007). Design and synthesis of novel hydantoin-containing melanin-concentrating hormone receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 17(13). 3754–3759. 11 indexed citations
2.
Changeux, Jean‐Pierre, Anne Devillers‐Thiéry, Jean‐Luc Galzi, & Frédéric Revah. (2007). The Acetylcholine Receptor: A Model of an Allosteric Membrane Protein Mediating Intercellular Communication. Novartis Foundation symposium. 164. 66–97. 9 indexed citations
3.
Nishiyama, Yoshitaka, Stéphane Miras, Christine Miège, et al.. (2003). Refolding from denatured inclusion bodies, purification to homogeneity and simplified assay of MGDG synthases from land plants. Protein Expression and Purification. 31(1). 79–87. 20 indexed citations
4.
Kennel, Philippe, Françoise Finiels, Daniel Scherman, et al.. (2002). Viral and non-viral gene therapy partially prevents experimental cisplatin-induced neuropathy. Gene Therapy. 9(19). 1333–1337. 25 indexed citations
5.
Kennel, Philippe, Frédéric Revah, Georg Andrees Böhme, et al.. (2000). Riluzole prolongs survival and delays muscle strength deterioration in mice with progressive motor neuronopathy (pmn). Journal of the Neurological Sciences. 180(1-2). 55–61. 28 indexed citations
6.
Malecaze, François, Bettina Couderc, Jacques Mallet, et al.. (1999). Adenovirus-Mediated Suicide Gene Transduction: Feasibility in Lens Epithelium and in Prevention of Posterior Capsule Opacification in Rabbits. Human Gene Therapy. 10(14). 2365–2372. 31 indexed citations
7.
Peltola, Minna, Aija Kyttälä, O. P. Heinonen, et al.. (1998). Adenovirus-mediated gene transfer results in decreased lysosomal storage in brain and total correction in liver of aspartylglucosaminuria (AGU) mouse. Gene Therapy. 5(10). 1314–1321. 31 indexed citations
8.
Bilang‐Bleuel, Alicia, Marie‐Hélène Buc‐Caron, Olga Corti, et al.. (1998). Adenovirus in the brain: recent advances of gene therapy for neurodegenerative diseases. Progress in Neurobiology. 55(4). 333–341. 74 indexed citations
9.
Blanchard, Véronique, Christian Czech, Bruno Bonici, et al.. (1997). Immunohistochemical analysis of presenilin 2 expression in the mouse brain: distribution pattern and co-localization with presenilin 1 protein. Brain Research. 758(1-2). 209–217. 25 indexed citations
10.
Haase, G, Philippe Kennel, Brigitte Pettmann, et al.. (1997). Gene therapy of murine motor neuron disease using adenoviral vectors for neurotrophic factors. Nature Medicine. 3(4). 429–436. 193 indexed citations
11.
Abitbol, Marc, et al.. (1997). In vivo adenovirus-mediated gene transfer to newborn rat retinal pigment epithelial cells. Comptes Rendus de l Académie des Sciences - Series III - Sciences de la Vie. 320(7). 523–532. 4 indexed citations
12.
Sabaté, Olivier, et al.. (1997). Adenovirus for neurodegenerative diseases: in vivo strategies and ex vivo gene therapy using human neural progenitors.. PubMed. 3(5). 317–21. 3 indexed citations
13.
Moussaoui, Saliha, Christian Czech, Laurent Pradier, et al.. (1996). Immunohistochemical analysis of presenilin‐1 expression in the mouse brain. FEBS Letters. 383(3). 219–222. 54 indexed citations
14.
Barkats, Martine, Alexis‐Pierre Bemelmans, Marie‐Claude Geoffroy, et al.. (1996). An adenovirus encoding CuZnSOD protects cultured striatal neurones against glutamate toxicity. Neuroreport. 7(2). 497–501. 22 indexed citations
15.
Boissière‐Michot, Florence, Laurent Pradier, P. Delaère, et al.. (1996). Regional and cellular presenilin 2 (STM2) gene expression in the human brain. Neuroreport. 7(12). 2021–2025. 8 indexed citations
16.
Barnéoud, Pascal, et al.. (1996). Direct Intracerebral Nerve Growth Factor Gene Transfer Using a Recombinant Adenovirus: Effect on Basal Forebrain Cholinergic Neurons during Aging. Neurobiology of Disease. 3(1). 76–86. 35 indexed citations
17.
18.
Galzi, Jean‐Luc, Daniel Bertrand, Anne Devillers‐Thiéry, et al.. (1991). Functional significance of aromatic amino acids from three peptide loops of the α7 neuronal nicotinic receptor site investigated by site‐directed mutagenesis. FEBS Letters. 294(3). 198–202. 144 indexed citations
19.
Galzi, Jean‐Luc, Frédéric Revah, Alain Bessis, & J.-P. Changeux. (1991). Functional Architecture of the Nicotinic Acetylcholine Receptor: From Electric Organ to Brain. The Annual Review of Pharmacology and Toxicology. 31(1). 37–72. 289 indexed citations
20.
Giraudat, Jérôme, et al.. (1989). The noncompetitive blocker [3H]chlorpromazine labels segment M2 but not segment M 1 of the nicotinic acetylcholine receptor α‐subunit. FEBS Letters. 253(1-2). 190–198. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James W. Patrick Breakdown of academic impact, for papers by Erik S. Schweitzer Breakdown of academic impact, for papers by William N. Green Breakdown of academic impact, for papers by Lucy Rhee Breakdown of academic impact, for papers by Kumi Kaneko Breakdown of academic impact, for papers by Emer S. Ferro Breakdown of academic impact, for papers by Bruce D. Howard Breakdown of academic impact, for papers by Aaron Voigt Breakdown of academic impact, for papers by Louis J. DeGennaro Breakdown of academic impact, for papers by Irith Ginzburg
Rankless by CCL
2026